{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:56:26Z","timestamp":1793217386909,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006396","name":"Alexion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals, Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ymgme.2019.11.004","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T11:58:31Z","timestamp":1574078311000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Initial assessment and ongoing monitoring of lysosomal acid lipase deficiency in children and adults: Consensus recommendations from an international collaborative working group"],"prefix":"10.1016","volume":"129","author":[{"given":"Rohit","family":"Kohli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Ratziu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Fiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Waldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don P.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Balwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ymgme.2019.11.004_bb0005","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1161\/ATVBAHA.113.302426","article-title":"Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia","volume":"33","author":"Stitziel","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.ymgme.2019.11.004_bb0010","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hep.26327","article-title":"Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>a) in various racial and ethnic groups","volume":"58","author":"Scott","year":"2013","journal-title":"Hepatology."},{"issue":"3","key":"10.1016\/j.ymgme.2019.11.004_bb0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA."},{"issue":"6","key":"10.1016\/j.ymgme.2019.11.004_bb0020","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jhep.2013.02.014","article-title":"Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease","volume":"58","author":"Bernstein","year":"2013","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.ymgme.2019.11.004_bb0025","doi-asserted-by":"crossref","first-page":"G836","DOI":"10.1152\/ajpgi.00243.2014","article-title":"Hepatic entrapment of esterified cholesterol drives continual expansion of whole body sterol pool in lysosomal acid lipase-deficient mice","volume":"307","author":"Aqul","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.ymgme.2019.11.004_bb0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","article-title":"Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction","volume":"235","author":"Reiner","year":"2014","journal-title":"Atherosclerosis."},{"issue":"4","key":"10.1016\/j.ymgme.2019.11.004_bb0035","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOL.0b013e328361f6c6","article-title":"Lysosomal acid lipase a and the hypercholesterolaemic phenotype","volume":"24","author":"Fouchier","year":"2013","journal-title":"Curr. Opin. Lipidol."},{"issue":"2","key":"10.1016\/j.ymgme.2019.11.004_bb0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MOL.0000000000000281","article-title":"Novel therapies for severe dyslipidemia originating from human genetics","volume":"27","author":"Gaudet","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"issue":"3","key":"10.1016\/j.ymgme.2019.11.004_bb0045","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3748\/wjg.v21.i3.1001","article-title":"Novel LIPA mutations in Mexican siblings with lysosomal acid lipase deficiency","volume":"21","author":"Santillan-Hernandez","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ymgme.2019.11.004_bb0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/geno.1996.0162","article-title":"Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity","volume":"33","author":"Aslanidis","year":"1996","journal-title":"Genomics."},{"issue":"1","key":"10.1016\/j.ymgme.2019.11.004_bb0055","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2018.09.028","article-title":"The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: a rare condition that mimics NAFLD","volume":"70","author":"Carter","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymgme.2019.11.004_bb0060","article-title":"Large-scale functional LIPA variant characterization to improve birth prevalence estimates of lysosomal acid lipase deficiency","author":"Del Angel","year":"2019","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2019.11.004_bb0065","author":"Human Gene Mutation Database (HGMD\u00ae)"},{"issue":"5","key":"10.1016\/j.ymgme.2019.11.004_bb0070","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jacl.2015.07.008","article-title":"Identification and metabolic profiling of patients with lysosomal acid lipase deficiency","volume":"9","author":"Pullinger","year":"2015","journal-title":"J Clin Lipidol."},{"issue":"1","key":"10.1016\/j.ymgme.2019.11.004_bb0075","first-page":"99","article-title":"Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease","volume":"35","author":"Tylki-Szymanska","year":"2014","journal-title":"Prilozi."},{"issue":"11","key":"10.1016\/j.ymgme.2019.11.004_bb0080","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/jclinpath-2012-201302","article-title":"Cholesteryl ester storage disease: a rare and possibly treatable cause of premature vascular disease and cirrhosis","volume":"66","author":"Reynolds","year":"2013","journal-title":"J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.ymgme.2019.11.004_bb0085","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MPG.0000000000000935","article-title":"Clinical features of lysosomal acid lipase deficiency - a longitudinal assessment of 48 children and adults","volume":"61","author":"Burton","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymgme.2019.11.004_bb0090","doi-asserted-by":"crossref","unstructured":"Maciejko JJ. Managing cardiovascular risk in lysosomal acid lipase deficiency. Am. J. Cardiovasc. Drugs. 2017 Jun 17(3):217-231. Doi: https:\/\/doi.org\/10.1007\/s40256-017-0216-5. Review. Erratum in: Am J Cardiovasc drugs. 2017 Jun;17 (3):233.","DOI":"10.1007\/s40256-017-0216-5"},{"key":"10.1016\/j.ymgme.2019.11.004_bb0095","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.ymgme.2017.12.036","article-title":"Lysosomal acid lipase deficiency is associated with premature death in children and adults","volume":"123","author":"Bernstein","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2019.11.004_bb0100","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jacl.2018.02.020","article-title":"Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency","volume":"12","author":"Wilson","year":"2018","journal-title":"J. Clin. Lipidol."},{"issue":"2","key":"10.1016\/j.ymgme.2019.11.004_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2016.11.002","article-title":"Lysosomal acid lipase deficiency: a hidden disease among cohorts of familial hypercholesterolemia?","volume":"11","author":"Chora","year":"2017","journal-title":"J. Clin. Lipidol."},{"issue":"11","key":"10.1016\/j.ymgme.2019.11.004_bb0110","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMe1509055","article-title":"Lysosomal acid lipase deficiency - a new therapy for a genetic lipid disease","volume":"373","author":"Rader","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2019.11.004_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymgme.2018.03.010","article-title":"Lysosomal acid lipase deficiency allograft recurrence and liver failure-clinical outcomes of 18 liver transplantation patients","volume":"124","author":"Bernstein","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2019.11.004_bb0120","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/gim.2015.108","article-title":"Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants","volume":"18","author":"Jones","year":"2016","journal-title":"Genet. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2019.11.004_bb0125","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ymgme.2013.03.007","article-title":"Unfavorable outcome of hematopoietic stem cell transplantation in two siblings with Wolman disease due to graft failure and hepatic complications","volume":"109","author":"Yanir","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.11.004_bb0130","series-title":"Kanuma [package insert]","year":"2015"},{"key":"10.1016\/j.ymgme.2019.11.004_bb0135","series-title":"Rueil-Malmaison","author":"Kanuma [summary of product characteristics]","year":"2015"},{"issue":"16","key":"10.1016\/j.ymgme.2019.11.004_bb0140","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/hmg\/10.16.1639","article-title":"Enzyme therapy for lysosomal acid lipase deficiency in the mouse","volume":"10","author":"Du","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.ymgme.2019.11.004_bb0145","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1086\/498652","article-title":"The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy","volume":"77","author":"Du","year":"2005","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.ymgme.2019.11.004_bb0150","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1194\/jlr.M700482-JLR200","article-title":"Wolman disease\/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice","volume":"49","author":"Du","year":"2008","journal-title":"J. Lipid Res."},{"issue":"11","key":"10.1016\/j.ymgme.2019.11.004_bb0155","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1501365","article-title":"A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency","volume":"373","author":"Burton","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ymgme.2019.11.004_bb0160","doi-asserted-by":"crossref","first-page":"429.e1","DOI":"10.1016\/j.medcli.2016.12.044","article-title":"Update on lysosomal acid lipase deficiency: diagnosis, treatment and patient management","volume":"148","author":"Camarena","year":"2017","journal-title":"Med. Clin. (Barc.)"},{"issue":"6","key":"10.1016\/j.ymgme.2019.11.004_bb0165","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/MPG.0b013e31828b36ac","article-title":"Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency","volume":"56","author":"Zhang","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymgme.2019.11.004_bb0170","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Lysosomal acid lipase deficiency: The continuous spectra of disease variants","author":"Grabowski","year":"2019"},{"issue":"10","key":"10.1016\/j.ymgme.2019.11.004_bb0175","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00431-014-2338-y","article-title":"Wolman disease associated with hemophagocytic lymphohistiocytosis: attempts for an explanation","volume":"173","author":"Taurisano","year":"2014","journal-title":"Eur. J. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2019.11.004_bb0180","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1210\/jc.2004-0016","article-title":"Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital, Montreal","volume":"90","author":"Perry","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2019.11.004_bb0185","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0168-8278(99)80356-0","article-title":"Hepatosplenomegalic lipidosis: what unless Gaucher?: adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase \u22121 exon 8 splice junction mutation","volume":"31","author":"vom Dahl","year":"1999","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.ymgme.2019.11.004_bb0190","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1365-2559.2011.04164.x","article-title":"Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimens","volume":"60","author":"Hulkova","year":"2012","journal-title":"Histopathology."},{"issue":"4","key":"10.1016\/j.ymgme.2019.11.004_bb0195","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0214","article-title":"Lysosomal acid lipase deficiency unmasked in two children with nonalcoholic fatty liver disease","volume":"138","author":"Himes","year":"2016","journal-title":"Pediatrics"},{"issue":"15\u201316","key":"10.1016\/j.ymgme.2019.11.004_bb0200","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cca.2012.03.019","article-title":"A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2","volume":"413","author":"Hamilton","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2019.11.004_bb0205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cca.2017.05.027","article-title":"Best practice in the measurement and interpretation of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2","volume":"471","author":"Lukacs","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2019.11.004_bb0210","series-title":"GeneReviews\u00ae","article-title":"Lysosomal acid lipase deficiency","author":"Hoffman","year":"2015"},{"issue":"7","key":"10.1016\/j.ymgme.2019.11.004_bb0215","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology."},{"issue":"8","key":"10.1016\/j.ymgme.2019.11.004_bb0220","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.metabol.2013.02.008","article-title":"Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia","volume":"62","author":"Martinez","year":"2013","journal-title":"Metabolism."},{"issue":"2","key":"10.1016\/j.ymgme.2019.11.004_bb0225","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacl.2015.02.003","article-title":"National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report","volume":"9","author":"Jacobson","year":"2015","journal-title":"J. Clin. Lipidol."},{"issue":"3","key":"10.1016\/j.ymgme.2019.11.004_bb0230","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-013-0394-9","article-title":"The role of advanced lipid testing in the prediction of cardiovascular disease","volume":"16","author":"Chandra","year":"2014","journal-title":"Curr. Atheroscler. Rep."},{"issue":"6","key":"10.1016\/j.ymgme.2019.11.004_bb0235","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0022-3476(77)80557-X","article-title":"Cholesterol ester storage disease: clinical, biochemical, and pathological studies","volume":"90","author":"Beaudet","year":"1977","journal-title":"J. Pediatr."},{"issue":"25","key":"10.1016\/j.ymgme.2019.11.004_bb0240","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1161\/CIR.0b013e3182051bab","article-title":"2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"122","author":"Greenland","year":"2010","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.ymgme.2019.11.004_bb0245","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jamacardio.2019.0777","article-title":"American Heart Association\/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol: primary prevention","volume":"4","author":"Grundy","year":"2018","journal-title":"JAMA Cardiol."},{"issue":"6","key":"10.1016\/j.ymgme.2019.11.004_bb0250","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamacardio.2019.0911","article-title":"2018 American Heart Association\/American College of Cardiology\/multisociety guideline on the Management of Blood Cholesterol-Secondary Prevention","volume":"4","author":"Grundy","year":"2019","journal-title":"JAMA Cardiol."},{"issue":"235","key":"10.1016\/j.ymgme.2019.11.004_bb0255","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/adc.44.235.331","article-title":"Wolman\u2019s disease: a rare lipidosis with adrenal calcification","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch. Dis. Child."},{"issue":"2","key":"10.1016\/j.ymgme.2019.11.004_bb0260","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","volume":"64","author":"Vos","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"9","key":"10.1016\/j.ymgme.2019.11.004_bb0265","first-page":"605","article-title":"Fibroscan (transient elastography) for the measurement of liver fibrosis","volume":"8","author":"Afdhal","year":"2012","journal-title":"Gastroenterol Hepatol (N Y)."},{"issue":"7","key":"10.1016\/j.ymgme.2019.11.004_bb0270","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2036.2004.01906.x","article-title":"Review article: hepatitis vaccination in patients with chronic liver disease","volume":"19","author":"Reiss","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.ymgme.2019.11.004_bb0275","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology."},{"issue":"1","key":"10.1016\/j.ymgme.2019.11.004_bb0280","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4274\/jcrpe.v3i1.02","article-title":"Serum alkaline phosphatase levels in healthy children and evaluation of alkaline phosphatase z-scores in different types of rickets","volume":"3","author":"Turan","year":"2011","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"2","key":"10.1016\/j.ymgme.2019.11.004_bb0285","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1148\/radiol.12120896","article-title":"Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis","volume":"267","author":"Tang","year":"2013","journal-title":"Radiology."},{"issue":"10","key":"10.1016\/j.ymgme.2019.11.004_bb0290","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"Fedchuk","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.ymgme.2019.11.004_bb0295","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology."},{"key":"10.1016\/j.ymgme.2019.11.004_bb0300","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-6-6","article-title":"Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Ratziu","year":"2006","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.ymgme.2019.11.004_bb0305","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jhep.2008.07.035","article-title":"Comparison of blood tests for liver fibrosis specific or not to NAFLD","volume":"50","author":"Cales","year":"2009","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.ymgme.2019.11.004_bb0310","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.ymgme.2019.11.004_bb0315","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MPG.0b013e31812e56ff","article-title":"Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy","volume":"45","author":"de Ledinghen","year":"2007","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"1","key":"10.1016\/j.ymgme.2019.11.004_bb0320","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/liv.12024","article-title":"Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease","volume":"33","author":"Alkhouri","year":"2013","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.ymgme.2019.11.004_bb0325","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/liv.12584","article-title":"The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"35","author":"Petta","year":"2015","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.ymgme.2019.11.004_bb0330","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.diii.2015.11.001","article-title":"Shear wave elastography: an accurate technique to stage liver fibrosis in chronic liver diseases","volume":"97","author":"Guibal","year":"2016","journal-title":"Diagn. Interv. Imaging."},{"issue":"3","key":"10.1016\/j.ymgme.2019.11.004_bb0335","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology."},{"issue":"9","key":"10.1016\/j.ymgme.2019.11.004_bb0340","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMicm1610060","article-title":"Cholesteryl Ester crystals in lysosomal acid lipase deficiency","volume":"376","author":"Ivashkin","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2019.11.004_bb0345","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","article-title":"Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Sumida","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.ymgme.2019.11.004_bb0350","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology."},{"issue":"9","key":"10.1016\/j.ymgme.2019.11.004_bb0355","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.humpath.2004.04.017","article-title":"Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens","volume":"35","author":"Brunt","year":"2004","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.ymgme.2019.11.004_bb0360","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hep.27173","article-title":"Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease","volume":"60","author":"Bedossa","year":"2014","journal-title":"Hepatology."},{"issue":"6","key":"10.1016\/j.ymgme.2019.11.004_bb0365","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.ymgme.2019.11.004_bb0370","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/kisup.2013.79","article-title":"Risk factors for chronic kidney disease: an update","volume":"3","author":"Kazancioglu","year":"2013","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.ymgme.2019.11.004_bb0375","first-page":"95","article-title":"End-stage renal disease in a patient with cholesteryl ester storage disease following successful liver transplantation and cyclosporine immunosuppression","volume":"20","author":"Kale","year":"1995","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"1","key":"10.1016\/j.ymgme.2019.11.004_bb0380","first-page":"30","article-title":"Case series of sebelipase alfa hypersensitivity reactions and successful sebelipase alfa rapid desensitization","volume":"49","author":"Huffaker","year":"2019","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2019.11.004_bb0385","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/TACG.S86760","article-title":"Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa","volume":"9","author":"Su","year":"2016","journal-title":"Appl. Clin. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2019.11.004_bb0390","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.yrtph.2009.03.012","article-title":"Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies","volume":"54","author":"Ponce","year":"2009","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"7","key":"10.1016\/j.ymgme.2019.11.004_bb0395","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2015.14","article-title":"Clinical development methodology for infusion-related reactions with monoclonal antibodies","volume":"4","author":"Doessegger","year":"2015","journal-title":"Clin. Transl. Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2019.11.004_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American Association of clinical endocrinologists and American College of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr. Pract."},{"issue":"6 Suppl","key":"10.1016\/j.ymgme.2019.11.004_bb0405","article-title":"National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ymgme.2019.11.004_bb0410","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","volume":"253","author":"Catapano","year":"2016","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ymgme.2019.11.004_bb0415","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2017-000598","article-title":"Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure","volume":"4","author":"Sato","year":"2017","journal-title":"Open. Heart."},{"issue":"7","key":"10.1016\/j.ymgme.2019.11.004_bb0420","first-page":"477","article-title":"APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD\/NASH","volume":"101","author":"Kruger","year":"2011","journal-title":"S. Afr. Med. J."},{"issue":"3","key":"10.1016\/j.ymgme.2019.11.004_bb0425","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ajg.2017.486","article-title":"Benefit of treatment with sebelipase alfa in a 63-year-old patient with advanced liver and atherosclerotic disease due to lysosomal acid lipase deficiency (LAL-D)","volume":"113","author":"Aigner","year":"2018","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.ymgme.2019.11.004_bb0430","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J. Hepatol."},{"issue":"24","key":"10.1016\/j.ymgme.2019.11.004_bb0435","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJM199712113372401","article-title":"Alcohol consumption and mortality among middle-aged and elderly U.S. adults","volume":"337","author":"Thun","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2019.11.004_bb0440","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O\u2019Shea","year":"2010","journal-title":"Hepatology."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219307358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219307358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:25:59Z","timestamp":1761089159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719219307358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1096719219307358"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.11.004","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initial assessment and ongoing monitoring of lysosomal acid lipase deficiency in children and adults: Consensus recommendations from an international collaborative working group","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}